 PONTE VEDRA, Fla., April 14, 2022 GLOBE NEWSWIRE -- Treace Medical Concepts, Inc. Treace NasdaqGS: TMCI, a medical technology company driving a paradigm shift in the surgical treatment of Hallux Valgus commonly known as bunions, today announced that it will release financial results for the first quarter of 2022 after the close of trading on Thursday, May 5, 2022. Company management will host a conference call to discuss financial results beginning at 4:30 p.m. ET. 